ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,054,000 | -20.8% | 16,619 | -64.8% | 0.42% | -34.8% |
| Q3 2019 | $1,330,000 | -46.5% | 47,186 | -49.7% | 0.65% | -38.8% |
| Q2 2019 | $2,486,000 | +30.2% | 93,796 | -9.9% | 1.06% | +25.1% |
| Q1 2019 | $1,909,000 | +37.0% | 104,056 | -7.2% | 0.84% | +10.9% |
| Q4 2018 | $1,393,000 | -45.1% | 112,124 | -15.3% | 0.76% | -25.9% |
| Q3 2018 | $2,538,000 | +74.8% | 132,379 | +24.0% | 1.03% | +45.0% |
| Q2 2018 | $1,452,000 | – | 106,795 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |